Literature DB >> 33838883

Prognostic importance of circumferential resection margin in the era of evolving surgical and multidisciplinary treatment of rectal cancer: A systematic review and meta-analysis.

Robin Detering1, Marieke L W Rutgers2, Willem A Bemelman2, Roel Hompes2, Pieter J Tanis2.   

Abstract

BACKGROUND: Circumferential resection margin is considered an important prognostic parameter after rectal cancer surgery, but its impact might have changed because of improved surgical quality and tailored multimodality treatment. The aim of this systematic review was to determine the prognostic importance of circumferential resection margin involvement based on the most recent literature.
METHODS: A systematic literature search of MEDLINE, Embase, and the Cochrane Library was performed for studies published between January 2006 and May 2019. Studies were included if 3- or 5-year oncological outcomes were reported depending on circumferential resection margin status. Outcome parameters were local recurrence, overall survival, disease-free survival, and distant metastasis rate. The Newcastle Ottawa Scale and Jadad score were used for quality assessment of the studies. Meta-analysis was performed using a random effects model and reported as a pooled odds ratio or hazard ratio with 95% confidence interval.
RESULTS: Seventy-five studies were included, comprising a total of 85,048 rectal cancer patients. Significant associations between circumferential resection margin involvement and all long-term outcome parameters were uniformly found, with varying odds ratios and hazard ratios depending on circumferential resection margin definition (<1 mm, ≤1 mm, otherwise), neoadjuvant treatment, study period, and geographical origin of the studies.
CONCLUSION: Circumferential resection margin involvement has remained an independent, poor prognostic factor for local recurrence and survival in most recent literature, indicating that circumferential resection margin status can still be used as a short-term surrogate endpoint.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33838883     DOI: 10.1016/j.surg.2021.02.029

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  4 in total

1.  Omission of neoadjuvant radiotherapy for clinical T2/N1 and T3N0/1 middle and low rectal cancers with safe circumferential resection margins.

Authors:  Kyung-Ha Lee; Jin-Soo Kim; Ji-Yeon Kim
Journal:  Ann Surg Treat Res       Date:  2022-05-03       Impact factor: 1.766

2.  Transanal Total Mesorectal Excision (TaTME) versus Laparoscopic Total Mesorectal Excision for Lower Rectal Cancer: A Propensity Score-Matched Analysis.

Authors:  Yueh-Chen Lin; Ya-Ting Kuo; Jeng-Fu You; Yih-Jong Chern; Yu-Jen Hsu; Yen-Lin Yu; Jy-Ming Chiang; Chien-Yuh Yeh; Pao-Shiu Hsieh; Chun-Kai Liao
Journal:  Cancers (Basel)       Date:  2022-08-24       Impact factor: 6.575

Review 3.  Pathological Features and Prognostication in Colorectal Cancer.

Authors:  Kabytto Chen; Geoffrey Collins; Henry Wang; James Wei Tatt Toh
Journal:  Curr Oncol       Date:  2021-12-13       Impact factor: 3.677

4.  Quantifying displacement of urogenital organs after abdominoperineal resection for rectal cancer.

Authors:  Sarah Sharabiany; Gaby J Strijk; Robin D Blok; Colin G Ferrett; Jaap Stoker; Christopher Cunningham; Jarmila D W van der Bilt; Anna A W van Geloven; Wilhelmus A Bemelman; Roel Hompes; Gijsbert D Musters; Pieter J Tanis
Journal:  Colorectal Dis       Date:  2021-09-08       Impact factor: 3.917

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.